@dansfera: Ever wonder why some big-money investors are steering clear of CROs? It’s not just about the numbers—it’s about the industry reaching a saturation point. The real disconnect isn't happening in the boardroom; it’s happening where advanced tech hits the messy reality of patient sites. When efficiency is already maxed out, the friction shifts to the ground level, and that’s where the real problems (and opportunities) are hiding. #CRO #InvestingInsights #Biotech #ClinicalTrials #StartupStrategy

dansfera

Open In TikTok:

Region: US

Thursday 02 April 2026 21:52:25 GMT